logo
 
Amid the global outbreak of Mpox, the World Health Organization (WHO) on Thursday announced prequalifying Bavarian Nordic’s vaccine — a first against the deadly monkeypox virus (MPXV).

Modified Vaccinia Ankara-Bavarian Nordic or MVA-BN is indicated for active immunisation against smallpox, Mpox, and related orthopoxvirus infections and disease in all adults 18 years of



age and older.

The vaccine can be administered as a 2-dose injection given 4 weeks apart.

“Available data shows that a single-dose MVA-BN vaccine given before exposure has an estimated 76 per cent effectiveness in protecting people against Mpox, with the 2-dose schedule achieving an estimated 82 per cent effectiveness,” the WHO said in a statement.
No Comments For This Post, Be first to write a Comment.
Leave a Comment
Name:
Email:
Comment:
Enter the code shown:


Can't read the image? click here to refresh
etemaad live tv watch now

Todays Epaper

English Weekly

neerus indian ethnic wear
Latest Urdu News

Which Women's cricket team will win the T20 World Cup 2024?

India
Australia
England